Market Overview:
Ultrasound cirrhosis detectors are used to detect the presence of cirrhosis in a patient. The ultrasound cirrhosis detectors market is segmented by type, application, and region. By type, the market is divided into non-invasive detection and minimally invasive detection. Non-invasive detection is further subdivided into handheld devices and scanners. Handheld devices are portable and easy to use; they are mostly used in clinics and hospitals for screening purposes. Scanners are large machines that use a transducer to produce images of the internal organs of a patient’s body; they are mostly used in hospitals for diagnosis purposes. By application, the market is divided into hospital, clinic, and other applications such as research institutes or forensic laboratories. Hospitals account for the majority of demand for ultrasound cirrhosis detectors owing to their high usage rates for diagnostic procedures.
Product Definition:
Ultrasound cirrhosis detectors are medical devices that are used to diagnose and monitor liver cirrhosis. They use ultrasound technology to create images of the liver that can be used to detect and assess the extent of damage caused by cirrhosis. Ultrasound cirrhosis detectors are an important tool for diagnosing and managing this condition.
Non-invasive Detection:
Non-invasive detection (NID) is a new term in the field of ultrasound cirrhosis detectors. It was introduced to avoid the misnomer “ultrasound scan” for non-invasive blood vessel imaging. The major advantage of NID over other diagnostic procedures is that it provides real time images and can be performed without making any incisions, which makes patients compliant.
Minimally Invasive Detection:
Minimally invasive detection is a new term in the field of ultrasound cirrhosis detectors. It was introduced to avoid complications and side effects associated with traditional methods of diagnosis. Minimally invasive procedures are less traumatic for patients as well as physicians, they cause lesser injury to the organ or tissue being examined, and they result in quicker recovery than invasive procedures. These advantages are expected to increase demand for minimally invasive detection over traditional methods during the forecast period.
Application Insights:
Based on the application, the market is segmented into hospital, clinic, and others. The hospital segment dominated the overall ultrasound cirrhosis detectors market in 2017 due to a high prevalence of chronic diseases such as heart conditions, cancer and diabetes that require regular medical checkups. In addition, an increase in healthcare spending by individuals across the globe has led to a rise in demand for advanced diagnostic equipment that can identify early signs of various diseases. Thus, factors such as rising healthcare spending and prevalence of chronic diseases are expected to drive demand over the forecast period.
The other application segment includes pre-surgical procedures performed before major surgeries or invasive procedures done under general anesthesia where patients need accurate diagnosis for proper treatment planning or post-operative care monitoring.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of key players, increasing prevalence of liver diseases and rising adoption of advanced technologies in this region. In addition, growing number of research activities by various organizations is also expected to drive the demand for these devices during the forecast period. For instance, as per a recent study published by National Institutes of Health (NIH), Ultrasound Portal-Ai Research Program has supported more than 80 studies since its inception in 2005 that includes more than 40 clinical trials with ultrasound technology for detection cirrhosis or HCCs at different stages from biopsy through final diagnosis.
Asia Pacific market is anticipated to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing prevalence of cirrhosis: The global prevalence of cirrhosis is increasing at an alarming rate. This is primarily due to the rising incidence of chronic liver diseases, such as hepatitis C and alcoholic liver disease. As a result, there is a growing demand for ultrasound cirrhosis detectors to help in the early diagnosis and treatment of this condition.
- Technological advancements: Ultrasound cirrhosis detectors are becoming increasingly sophisticated with each passing year, thanks to ongoing technological advancements. This has led to increased accuracy and precision in diagnosing cirrhosis, which is driving demand for these devices worldwide.
- Growing awareness about early detection: There is a growing awareness among people about the importance of early detection of diseases, including cirrhosis. This has led to an increase in demand for ultrasound cirrhosis detectors as they can help detect the condition at an early stage when it can be treated effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ultrasound Cirrhosis Detectors Market Research Report
By Type
Non-invasive Detection, Minimally Invasive Detection
By Application
Hospital, Clinic, Other
By Companies
Philips, GE Healthcare, Johnson & Johnson, Siemens Healthineers, Baxter, Canon Medical, Wuxi Hisky Medical, Lepu (Beijing) Medical, ET-Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Ultrasound Cirrhosis Detectors Market Report Segments:
The global Ultrasound Cirrhosis Detectors market is segmented on the basis of:
Types
Non-invasive Detection, Minimally Invasive Detection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips
- GE Healthcare
- Johnson & Johnson
- Siemens Healthineers
- Baxter
- Canon Medical
- Wuxi Hisky Medical
- Lepu (Beijing) Medical
- ET-Group
Highlights of The Ultrasound Cirrhosis Detectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-invasive Detection
- Minimally Invasive Detection
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ultrasound Cirrhosis Detectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ultrasound cirrhosis detectors are medical devices that use ultrasound to detect the presence of liver cirrhosis. These devices can be used to help doctors diagnose and monitor the progression of liver cirrhosis. Ultrasound is a type of radiation that uses sound waves to create images or videos. Liver cirrhosis is a condition in which the liver becomes damaged due to alcohol abuse or other causes. The damage can lead to scarring and inflammation, which can make it difficult for the liverto function properly. Ultrasound detectors are often used in conjunction with other tests such as blood tests and x-rays, in order to determine whether or not someone has Liver Cirrhosis
Some of the major companies in the ultrasound cirrhosis detectors market are Philips, GE Healthcare, Johnson & Johnson, Siemens Healthineers, Baxter, Canon Medical, Wuxi Hisky Medical, Lepu (Beijing) Medical, ET-Group.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ultrasound Cirrhosis Detectors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ultrasound Cirrhosis Detectors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ultrasound Cirrhosis Detectors Market - Supply Chain
4.5. Global Ultrasound Cirrhosis Detectors Market Forecast
4.5.1. Ultrasound Cirrhosis Detectors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ultrasound Cirrhosis Detectors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ultrasound Cirrhosis Detectors Market Absolute $ Opportunity
5. Global Ultrasound Cirrhosis Detectors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
5.3.1. Non-invasive Detection
5.3.2. Minimally Invasive Detection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ultrasound Cirrhosis Detectors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ultrasound Cirrhosis Detectors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ultrasound Cirrhosis Detectors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ultrasound Cirrhosis Detectors Demand Share Forecast, 2019-2026
9. North America Ultrasound Cirrhosis Detectors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
9.7.1. Non-invasive Detection
9.7.2. Minimally Invasive Detection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ultrasound Cirrhosis Detectors Demand Share Forecast, 2019-2026
10. Latin America Ultrasound Cirrhosis Detectors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
10.7.1. Non-invasive Detection
10.7.2. Minimally Invasive Detection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ultrasound Cirrhosis Detectors Demand Share Forecast, 2019-2026
11. Europe Ultrasound Cirrhosis Detectors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
11.7.1. Non-invasive Detection
11.7.2. Minimally Invasive Detection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ultrasound Cirrhosis Detectors Demand Share, 2019-2026
12. Asia Pacific Ultrasound Cirrhosis Detectors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
12.7.1. Non-invasive Detection
12.7.2. Minimally Invasive Detection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ultrasound Cirrhosis Detectors Demand Share, 2019-2026
13. Middle East & Africa Ultrasound Cirrhosis Detectors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ultrasound Cirrhosis Detectors Market Size and Volume Forecast by Type
13.7.1. Non-invasive Detection
13.7.2. Minimally Invasive Detection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ultrasound Cirrhosis Detectors Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ultrasound Cirrhosis Detectors Market: Market Share Analysis
14.2. Ultrasound Cirrhosis Detectors Distributors and Customers
14.3. Ultrasound Cirrhosis Detectors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Philips
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens Healthineers
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Baxter
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Canon Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wuxi Hisky Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lepu (Beijing) Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ET-Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
